Viewing Study NCT03742661


Ignite Creation Date: 2025-12-24 @ 12:08 PM
Ignite Modification Date: 2026-01-26 @ 6:04 AM
Study NCT ID: NCT03742661
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2019-07-10
First Post: 2018-08-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Impact of SPEACĀ® System Data on Therapeutic Decisions Related to Convulsive Seizure Patients With a New Diagnosis
Sponsor: Brain Sentinel
Organization:

Study Overview

Official Title: Impact of SPEACĀ® System Data on Therapeutic Decisions Related to Convulsive Seizure Patients With a New Diagnosis
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2019-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is an open label, randomized, prospective study of the impact on healthcare utilization of a surface Electromyography (sEMG) based seizure monitoring and alerting system for Veterans with a history of motor seizures (epileptic, non-epileptic or unknown) with upper extremity motor involvement, presenting with questionable spell characterization, taking place in the home setting.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: True
Is an FDA AA801 Violation?: